Cover Image
市場調查報告書

人工水晶體 (IOL) :醫療設備的開發平台評估

Intra Ocular Lens (IOL) - Medical Devices Pipeline Assessment, 2015

出版商 GlobalData 商品編碼 350914
出版日期 內容資訊 英文 292 Pages
訂單完成後即時交付
價格
Back to Top
人工水晶體 (IOL) :醫療設備的開發平台評估 Intra Ocular Lens (IOL) - Medical Devices Pipeline Assessment, 2015
出版日期: 2016年01月01日 內容資訊: 英文 292 Pages
簡介

本報告提供人工水晶體 (IOL) 的開發中產品調查分析,以各開發階段比較分析為焦點,提供您正在開發開發中產品的主要企業,進行中的臨床試驗相關資訊等系統性資訊。

第1章 目錄

第2章 簡介

  • 人工水晶體 (IOL) 概要

第3章 開發中的產品

  • 人工水晶體 (IOL) - 開發中產品:各開發階段
  • 人工水晶體 (IOL) - 開發中產品:各市場區隔
  • 人工水晶體 (IOL) - 開發中產品:各地區
  • 人工水晶體 (IOL) - 開發中產品:法規別
  • 人工水晶體 (IOL) - 開發中產品:核准預定日別
  • 人工水晶體 (IOL) - 進行中的臨床試驗

第4章 人工水晶體 (IOL) - 正在開發的開發中產品:各企業

  • 人工水晶體 (IOL) 企業 - 開發中產品:各開發階段
  • 人工水晶體 (IOL) - 開發中產品:各開發階段

第5章 人工水晶體 (IOL) 企業與產品概要

  • Abbott Medical Optics, Inc.
  • Adoptics AG
  • AkkoLens International BV
  • Alcon, Inc.
  • Anew Optics, Inc.
  • Bausch & Lomb Incorporated
  • Calhoun Vision, Inc.
  • Elenza, Inc.
  • Eye4Vision Ophthalmics International
  • EyeKon Medical, Inc.
  • Hoya Surgical Optics, Inc.
  • HumanOptics AG
  • Imperial Medical Technologies, Inc
  • InnFocus LLC
  • Innovia LLC
  • LensGen, Inc.
  • Lenstec, Inc.
  • London Eye Hospital Pharma
  • Massachusetts Institute of Technology
  • Meir Medical Center
  • Morcher Gmbh
  • NuLens Ltd.
  • Oculentis GmbH
  • PowerVision, Inc.
  • Presbeasy
  • Rayner Intraocular Lenses Limited
  • Sharklet Technologies, Inc.
  • STAAR Surgical Company
  • TEKIA, Inc.
  • University of Rochester
  • University of Tampere
  • Visioneering Technologies, Inc.
  • Washington University in St. Louis
  • Xend
  • Z Lens LLC

第6章 人工水晶體 (IOL) - 最近的趨勢

第7章 附錄

圖表

目錄
Product Code: GDME0133EPD

GlobalData's Medical Devices sector report, "Intra Ocular Lens (IOL) - Medical Devices Pipeline Assessment, 2015" provides an overview of Intra Ocular Lens (IOL) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Intra Ocular Lens (IOL) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Intra Ocular Lens (IOL) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Intra Ocular Lens (IOL) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Intra Ocular Lens (IOL) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Intra Ocular Lens (IOL) Overview

3. Products under Development

  • 3.1. Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development
  • 3.2. Intra Ocular Lens (IOL) - Pipeline Products by Segment
  • 3.3. Intra Ocular Lens (IOL) - Pipeline Products by Territory
  • 3.4. Intra Ocular Lens (IOL) - Pipeline Products by Regulatory Path
  • 3.5. Intra Ocular Lens (IOL) - Pipeline Products by Estimated Approval Date
  • 3.6. Intra Ocular Lens (IOL) - Ongoing Clinical Trials

4. Intra Ocular Lens (IOL) - Pipeline Products under Development by Companies

  • 4.1. Intra Ocular Lens (IOL) Companies - Pipeline Products by Stage of Development
  • 4.2. Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development

5. Intra Ocular Lens (IOL) Companies and Product Overview

  • 5.1. Abbott Medical Optics, Inc. Company Overview
    • 5.1.1. Abbott Medical Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Adoptics AG Company Overview
    • 5.2.1. Adoptics AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. AkkoLens International BV Company Overview
    • 5.3.1. AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Alcon, Inc. Company Overview
    • 5.4.1. Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Anew Optics, Inc. Company Overview
    • 5.5.1. Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Bausch & Lomb Incorporated Company Overview
    • 5.6.1. Bausch & Lomb Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Calhoun Vision, Inc. Company Overview
    • 5.7.1. Calhoun Vision, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Elenza, Inc. Company Overview
    • 5.8.1. Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Eye4Vision Ophthalmics International Company Overview
    • 5.9.1. Eye4Vision Ophthalmics International Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. EyeKon Medical, Inc. Company Overview
    • 5.10.1. EyeKon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Hoya Surgical Optics, Inc. Company Overview
    • 5.11.1. Hoya Surgical Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. HumanOptics AG Company Overview
    • 5.12.1. HumanOptics AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Imperial Medical Technologies, Inc Company Overview
    • 5.13.1. Imperial Medical Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. InnFocus LLC Company Overview
    • 5.14.1. InnFocus LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Innovia LLC Company Overview
    • 5.15.1. Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. LensGen, Inc. Company Overview
    • 5.16.1. LensGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Lenstec, Inc. Company Overview
    • 5.17.1. Lenstec, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. London Eye Hospital Pharma Company Overview
    • 5.18.1. London Eye Hospital Pharma Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Massachusetts Institute of Technology Company Overview
    • 5.19.1. Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Meir Medical Center Company Overview
    • 5.20.1. Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Morcher Gmbh Company Overview
    • 5.21.1. Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. NuLens Ltd. Company Overview
    • 5.22.1. NuLens Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Oculentis GmbH Company Overview
    • 5.23.1. Oculentis GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. PowerVision, Inc. Company Overview
    • 5.24.1. PowerVision, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Presbeasy Company Overview
    • 5.25.1. Presbeasy Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Rayner Intraocular Lenses Limited Company Overview
    • 5.26.1. Rayner Intraocular Lenses Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Sharklet Technologies, Inc. Company Overview
    • 5.27.1. Sharklet Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. STAAR Surgical Company Company Overview
    • 5.28.1. STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. TEKIA, Inc. Company Overview
    • 5.29.1. TEKIA, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. University of Rochester Company Overview
    • 5.30.1. University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. University of Tampere Company Overview
    • 5.31.1. University of Tampere Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Visioneering Technologies, Inc. Company Overview
    • 5.32.1. Visioneering Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. Washington University in St. Louis Company Overview
    • 5.33.1. Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. Xend Company Overview
    • 5.34.1. Xend Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. Z Lens LLC Company Overview
    • 5.35.1. Z Lens LLC Pipeline Products & Ongoing Clinical Trials Overview

6. Intra Ocular Lens (IOL)- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development
  • Table 2: Intra Ocular Lens (IOL) - Pipeline Products by Segment
  • Table 3: Intra Ocular Lens (IOL) - Pipeline Products by Territory
  • Table 4: Intra Ocular Lens (IOL) - Pipeline Products by Regulatory Path
  • Table 5: Intra Ocular Lens (IOL) - Pipeline Products by Estimated Approval Date
  • Table 6: Intra Ocular Lens (IOL) - Ongoing Clinical Trials
  • Table 7: Intra Ocular Lens (IOL) Companies - Pipeline Products by Stage of Development
  • Table 8: Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development
  • Table 9: Abbott Medical Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Intraocular Lens - Astigmatism - Product Status
  • Table 11: Intraocular Lens - Astigmatism - Product Description
  • Table 12: Intraocular Lens - Presbyopia - Product Status
  • Table 13: Intraocular Lens - Presbyopia - Product Description
  • Table 14: Modified Light Transmission IOL - Product Status
  • Table 15: Modified Light Transmission IOL - Product Description
  • Table 16: Synchrony Dual Optic Accommodating IOL - Enhanced Version - Product Status
  • Table 17: Synchrony Dual Optic Accommodating IOL - Enhanced Version - Product Description
  • Table 18: TECNIS-1 Monofocal IOL - Product Status
  • Table 19: TECNIS-1 Monofocal IOL - Product Description
  • Table 20: Adoptics AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Shape-Changing Accommodating Intraocular Lens - Product Status
  • Table 22: Shape-Changing Accommodating Intraocular Lens - Product Description
  • Table 23: AkkoLens International BV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: AkkoLens AIOL - Product Status
  • Table 25: AkkoLens AIOL - Product Description
  • Table 26: Alcon, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Accommodative Intraocular Lens - Product Status
  • Table 28: Accommodative Intraocular Lens - Product Description
  • Table 29: AcrySof Cachet Angle-Supported Phakic Lens - Product Status
  • Table 30: AcrySof Cachet Angle-Supported Phakic Lens - Product Description
  • Table 31: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Status
  • Table 32: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Description
  • Table 33: AcrySof IQ ReSTOR 3.0D Toric IOL - Product Status
  • Table 34: AcrySof IQ ReSTOR 3.0D Toric IOL - Product Description
  • Table 35: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Status
  • Table 36: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Description
  • Table 37: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Status
  • Table 38: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Description
  • Table 39: AcrySof IQ ReSTOR Multifocal Toric Lens - Product Status
  • Table 40: AcrySof IQ ReSTOR Multifocal Toric Lens - Product Description
  • Table 41: AcrySof IQ ReSTOR Toric IOL 2.5D - Product Status
  • Table 42: AcrySof IQ ReSTOR Toric IOL 2.5D - Product Description
  • Table 43: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Status
  • Table 44: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Description
  • Table 45: AcrySof IQ Toric Diopter Range Expansion - Product Status
  • Table 46: AcrySof IQ Toric Diopter Range Expansion - Product Description
  • Table 47: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Status
  • Table 48: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Description
  • Table 49: Intrepid IOL - Product Status
  • Table 50: Intrepid IOL - Product Description
  • Table 51: Alcon, Inc. - Ongoing Clinical Trials Overview
  • Table 52: AcrySof IQ ReSTOR Multifocal Toric Lens - Evaluation of the Visual Acuity After the Implantation of a ReSTOR +2.5 Diopters Intraocular Lens (ReSTOR SV25T0) in the Distance Dominant Eye, in Combination With a +3.0 Diopters ReSTOR Intraocular Lens (ReSTOR SN6AD1) in the Fellow Eye
  • Table 53: Anew Optics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Zephyr Lens - Product Status
  • Table 55: Zephyr Lens - Product Description
  • Table 56: Bausch & Lomb Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: Sarfarazi Elliptical Accommodating IOL - Product Status
  • Table 58: Sarfarazi Elliptical Accommodating IOL - Product Description
  • Table 59: Calhoun Vision, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Light Adjustable Lens - Product Status
  • Table 61: Light Adjustable Lens - Product Description
  • Table 62: Elenza, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 63: Sapphire Autofocal IOL - Product Status
  • Table 64: Sapphire Autofocal IOL - Product Description
  • Table 65: Eye4Vision Ophthalmics International Pipeline Products & Ongoing Clinical Trials Overview
  • Table 66: HYDROPHOBICx - Product Status
  • Table 67: HYDROPHOBICx - Product Description
  • Table 68: EyeKon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: ACUITY FA55A-4NY IOL - Product Status
  • Table 70: ACUITY FA55A-4NY IOL - Product Description
  • Table 71: Acuity FA55A-4UV IOL - Product Status
  • Table 72: Acuity FA55A-4UV IOL - Product Description
  • Table 73: Acuity FB25B - UV IOL - Product Status
  • Table 74: Acuity FB25B - UV IOL - Product Description
  • Table 75: Acuity FB25B-NY IOL - Product Status
  • Table 76: Acuity FB25B-NY IOL - Product Description
  • Table 77: Acuity FS25B-NY IOL - Product Status
  • Table 78: Acuity FS25B-NY IOL - Product Description
  • Table 79: Acuity FS25B-UV IOL - Product Status
  • Table 80: Acuity FS25B-UV IOL - Product Description
  • Table 81: Acuity FS60S - 4NY IOL - Product Status
  • Table 82: Acuity FS60S - 4NY IOL - Product Description
  • Table 83: Acuity FS60S - 4UV IOL - Product Status
  • Table 84: Acuity FS60S - 4UV IOL - Product Description
  • Table 85: Acuity SB25B IOL - Product Status
  • Table 86: Acuity SB25B IOL - Product Description
  • Table 87: Acuity SB25B-NY IOL - Product Status
  • Table 88: Acuity SB25B-NY IOL - Product Description
  • Table 89: Acuity TN60 - 2NY IOL - Product Status
  • Table 90: Acuity TN60 - 2NY IOL - Product Description
  • Table 91: Acuity TN60-OUV IOL - Product Status
  • Table 92: Acuity TN60-OUV IOL - Product Description
  • Table 93: Acuity UB60-0UV IOL - Product Status
  • Table 94: Acuity UB60-0UV IOL - Product Description
  • Table 95: Acuity UY60 - OUV IOL - Product Status
  • Table 96: Acuity UY60 - OUV IOL - Product Description
  • Table 97: Acurus AA55A-41 IOL - Product Status
  • Table 98: Acurus AA55A-41 IOL - Product Description
  • Table 99: Acurus AA55A-44 IOL - Product Status
  • Table 100: Acurus AA55A-44 IOL - Product Description
  • Table 101: Acurus AB25B IOL - Product Status
  • Table 102: Acurus AB25B IOL - Product Description
  • Table 103: Acurus AB25BNY IOL - Product Status
  • Table 104: Acurus AB25BNY IOL - Product Description
  • Table 105: Acurus AB60 - OUV IOL - Product Status
  • Table 106: Acurus AB60 - OUV IOL - Product Description
  • Table 107: ACURUS AR60S-4 IOL - Product Status
  • Table 108: ACURUS AR60S-4 IOL - Product Description
  • Table 109: Acurus AY60 - OUV IOL - Product Status
  • Table 110: Acurus AY60 - OUV IOL - Product Description
  • Table 111: Acurus SB25B - NY IOL - Product Status
  • Table 112: Acurus SB25B - NY IOL - Product Description
  • Table 113: Acurus SB25B IOL - Product Status
  • Table 114: Acurus SB25B IOL - Product Description
  • Table 115: ACURUS UN60-2NY IOL - Product Status
  • Table 116: ACURUS UN60-2NY IOL - Product Description
  • Table 117: ACURUS UN60-OUV IOL - Product Status
  • Table 118: ACURUS UN60-OUV IOL - Product Description

List of Figures

  • Figure 1: Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development
  • Figure 2: Intra Ocular Lens (IOL) - Pipeline Products by Segment
  • Figure 3: Intra Ocular Lens (IOL) - Pipeline Products by Territory
  • Figure 4: Intra Ocular Lens (IOL) - Pipeline Products by Regulatory Path
  • Figure 5: Intra Ocular Lens (IOL) - Pipeline Products by Estimated Approval Date
  • Figure 6: Intra Ocular Lens (IOL) - Ongoing Clinical Trials
Back to Top